AbbVie ROE - Return on Equity 2010-2024 | ABBV

AbbVie return on equity for the quarter ending September 30, 2024 was 81.09.

  • AbbVie average return on equity for 2023 was 48.66, a 41% increase from 2022.
  • AbbVie average return on equity for 2022 was 82.47, a 46.41% decline from 2021.
  • AbbVie average return on equity for 2021 was 56.33, a 245.93% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

AbbVie ROE - Return on Equity 2010-2024 | ABBV

  • AbbVie average return on equity for 2023 was 48.66, a 41% increase from 2022.
  • AbbVie average return on equity for 2022 was 82.47, a 46.41% decline from 2021.
  • AbbVie average return on equity for 2021 was 56.33, a 245.93% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.